Atlas Oncology Partners today announced the closing of its Series A financing. Atlas was founded by Rubicon Founders, a healthcare investment firm focused on building and growing companies that transform the way people receive care. The financing round was led by Flare Capital Partners with significant participation from Rubicon Founders.

The $28 million funding round will be used to expand Atlas' geographic footprint with more oncology practice partners and invest in clinical and operational infrastructure.